Gastrointestinal transit of a matrix tablet formulation: comparison of canine and human data

SS Davis, EA Wilding, IR Wilding - International journal of pharmaceutics, 1993 - Elsevier
Controlled release devices, based on high molecular weight hydrophilic polymers, have
been shown in studies in dogs to have extended gastric retentive properties. However, the …

High viscosity hydroxypropylmethylcellulose reduces postprandial blood glucose concentrations in NIDDM patients

C Reppas, CH Adair, JL Barnett, RR Berardi… - Diabetes research and …, 1993 - Elsevier
The ability of high viscosity hydroxypropylmethylcellulose (HPMC) to reduce postprandial
glucose concentrations was assessed in patients with non-insulin-dependent diabetes …

Biopharmaceutics of didanosine in humans and in a model for acid-labile drugs, the pentagastrin-pretreated dog

CA Knupp, WC Shyu, EA Morgenthien, JS Lee… - Pharmaceutical …, 1993 - Springer
Didanosine is a purine nucleoside analogue approved for the treatment of human
immunodeficiency virus infection. It is extremely unstable at pH values less than 3 and …

Evaluation of sustained-release granules of chlorphenesin carbamate in dogs and humans

A Masayuki, F Atsushi, M Tohru, Y Kenji… - International journal of …, 1993 - Elsevier
The bioavailability and pharmacokinetic properties of two sustained-release (SR)
formulations of chlorphenesin carbamate (CPC) with different in vitro release rates were …

A new slow release formulation of metoprolol: In-vitro and in-vivo evaluation in dogs

P Albin, A Markus, Z Ben-Zvi, Z Pelah - Journal of controlled release, 1993 - Elsevier
Metoprolol, a β 1-adrenergic blocker, was formulated into a number of sustained-release
formulations. Some of these were prepared by a spray-drying technique specially developed …

[图书][B] The gastrointestinal absorption characteristics of ranitidine: The influence on the double peak phenomenon

AB Suttle III - 1993 - search.proquest.com
Double peaks in the plasma concentration-time profile after oral administration have been
reported for several compounds. A pharmacokinetic model incorporating discontinuous GI …